Process and Automation

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, reviews the company’s latest moves in targeting automation.

As new analytical technologies advance, insight into the twin-screw granulation process is growing.

SCHOTT now offers ViewCell, a new component meant to add flexibility to biopharmaceutical process control.

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

EMS is a leader in the cleanroom industry, delivering complete cleanroom monitoring and control solutions, services to customers, and ensuring quality by design from inception to process control.

FDA is anticipating how AI may advance manufacturing and improve supply chain security.

Bristol Myers Squibb has joined Cellares’ Technology Adoption Partnership program just as Cellares launches operations as an integrated development and manufacturing organization.

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Manufacturers face the challenge of meeting growing demand for personalized biopharmaceuticals.

The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.

The results found that repeatability testing found all 15 processes to be with in specification for target final concentration.

Monil Malhotra, vice-president of Industrial Software at Emerson, discusses the growing demand for software solutions in the pharma industry.

Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.

Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.

Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.

As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.

Organizations can better understand the maturity of AI-driven automation technology across their organization’s IT landscape through effective pharmacovigilance.

PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

Manufacturers automate production lines and increase the use of third-party providers.

One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.

Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.

Replacing a step in sample preparation with an automated approach improves both method precision and productivity.

External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.

Automation enables intensification of downstream processes.

Automated finished product inspection has been widely adopted in the bio/pharmaceutical industry.

Integrating digital technologies into lab environments can ease workflow and enhance data capture for researchers.

Point-of-use manufacturing may lead to a big change in the accessibility of medicines globally.

Automation and digitalization work together in the digital plant.